Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 860 results for "mylan"

Court Grants Summary Judgment in Favor of Mylan and FDA Related to Generic Precedex
Wall Street Select

Mylan Inc. Commences Phase 3 Clinical Trials For Its Generic V...

PITTSBURGH , Sept. 16, 2014 /PRNewswire/ --Mylan Inc. (Nasdaq: MYL), one of the world's leading global pharmaceutical companies, today announced it is initiating Phase III clinical trials for its generic version of GlaxoSmithKline's Advair Diskus® ... BioSpace, 5 hours ago

132 images for mylan

BioSpace, 6 days ago
Pharma Letter, 5 hours ago
FDA News, 1 day ago
Drug Discovery and Development, 5 days ago
PHP Developer's Journal, 3 days ago
ABC News 4 Charleston, 3 days ago
CNBC Africa, 4 days ago
FiercePharma, 6 days ago
Pittsburgh Business Times, 6 days ago
Pittsburgh Business Times, 6 days ago

Drug makers sign pact with Gilead for cheaper Hepatitis-C drug

Seven India-based drug makers Cipla, Ranbaxy, Mylan, Strides Arcolab, Hetero, Cadila Healthcare and Sequent Scientific — have signed a licensing agreement with Gilead, a multinational drug company, which allows the generic drug makers to ...
 Business Standard India1 day ago Mylan, Gilead Join Hands For Generic Version of Sovaldi  Bidness Etc1 day ago Gilead Licenses Hepatitis Therapy in India Amid Price Criticism  BusinessWeek1 day ago Gilead Licenses Sovaldi to Mylan, Others For Developing Markets  Washington Post1 day ago
Business Standard

Venus Remedies surges 18% in three days on marketing tie-up with Mylan

The company has entered into a distribution-cum-outlicensing agreement with Mylan for marketing its generic broad-spectrum antibiotic 'Meropenem' in three European countries. SI Reporter | Mumbai September 10, 2014 Last Updated at 09:42 IST Venus Remedies has ...
 Business Standard6 days ago Venus Pharma inks pact with Mylan for marketing meropenem in 3 European countries  Business Standard1 week ago Venus arm in marketing tie-up with Mylan  Business Standard1 week ago Venus Remedies up 7%, ties up with Mylan to sell antibiotic  Money Control1 week ago

Venus Remedies up on pact with Mylan

In terms of volume, 3.14 lakh shares of the company changed hands at the BSE, while over 11 lakh shares were traded at the NSE during the day. MUMBAI: Shares of Venus Remedies surged over 8 per cent as Venus Pharma GmbH, a subsidiary of the pharma major ...
 Economic Times1 week ago Venus Remedies shares up as unit enters into pact with Mylan  Business Standard1 week ago Venus Remedies surges as unit enters into pact with Mylan  Business Standard1 week ago Venus Remedies slumps 15% post Crisil downgrade  Moneycontrol.com15 hours ago
Business Standard India

Strides Arcolab up 3%, Macquarie says dividend to drive it

During the last earnings call, Strides Arcolab had highlighted that from USD 390 million of receivables from Mylan, it expects contingent holdback (of USD 250 million) to get released in Q2 FY15. With 20 days left for Q2FY15 end, dividend could be a near-term ...
 Money Control4 days ago Strides Arcolab promoter bags deals from Gilead  Business Standard India1 day ago Buy Strides Arcolab; target of Rs 900: Religare Capital  Moneycontrol.com4 days ago

VENUS REMEDIES : Eyes $15 million from antibiotic; ties up with mylan

Venus Remedies Ltd expects to report revenue of $15 million from its antibiotic drug, Meropenem, in the next one year. The company has tied up with Mylan to market the drug in European countries. Venus will manufacture the drug at the ...
 4 Traders6 days ago Venus eyes USD 15 mn from meropenem; ties up with Mylan  Business Standard1 week ago
Business Standard

Mylan's ANDA for Three Times Per Week Generic Copaxone 40 mg/mL Accepted for Filing by FDA

By a News Reporter-Staff News Editor at Pharma Business Week Mylan Inc. (Nasdaq: MYL) announced that its abbreviated new drug application (ANDA) for a three times per week Glatiramer Acetate Injection 40 mg/mL has been accepted for filing by the ...
 Pharmacy Choice1 week ago Natco Pharma gains 5%; hits 52-week high  Business Standard2 weeks ago Natco Pharma hits record high  Business Standard2 weeks ago Natco Pharma at record high; partner Mylan files ANDA  Money Control2 weeks ago
Business Standard

Cipla, Mylan, Micro Labs, Aurobindo, Emcure ink licensing pact for antiretrovirals with a UN unit

Medicines Patent Pool has signed seven new sub-licences for generic HIV medicines with Cipla, Mylan, Micro Labs, Aurobindo, Laurus Labs, Emcure and Desano (a Chinese manufacturer) BS B2B Bureau | Mumbai July 17, 2014 Last Updated at 16:48 IST Medicines Patent ...
 Business Standard2 months ago

Mylan to appeal EC anti-trust findings against Matrix

Drugmaker Mylan will appeal the European Commisions recent anti-trust findings and fine imposed on its subsidiary, the erstwhile Matrix Laboratories. The decision relates to a settlement agreement entered into by Matrix with Les Laboratoires Servier in 2005 ...
 Business Line2 months ago

EC slaps fine on Lupin, Unichem Labs, Mylan Unit

As per the European Commission Anti-trust ruling, Lupin has been fined 40 million euros, while Unichem Laboratories 13.96 million euros. MUMBAI: The European Commission's antitrust authorities have slapped a fine of 427.7 million euros on a group of ...
 Economic Times2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - mylan
Get updated on latest news & your favorite topics right in your inbox!
More     Less